New medicine assessment change backed

The NHS should work more closely with manufacturers on assessing the benefits of new medicines rather than simply blocking access, the drug industry believes.

New drugs: UK use is low
New drugs: UK use is low

Dr Richard Barker, director general of the Association of the British Pharmaceutical Industry, said restricting access to drugs led to patients missing out on the best care available.

This means patients cannot be included in many trials and creates a spiral in which care in the UK falls behind that in other countries, he said.

Dr Barker said NICE should recognise that when a drug is launched there may be limited data as to its effectiveness and value to the NHS in practice.

Rather than blocking access, the NHS should be allowed to use the drug and studies undertaken of how patients are benefitting, he said.

The NHS could then, he argued, become a 'living laboratory for healthcare innovation'.

Dr John Jeans, chief operating officer of the Medical Research Council, said the NHS should look at whether it could cut costs simply by checking whether drugs are benefitting particular patients or not.

The health White Paper aims to reform the way that drug companies are paid for NHS medicines.

It hopes a value-based pricing system will improve NHS access to effective drugs and innovative treatment.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

More than 80% of patients report 'good' overall experience of general practice

More than 80% of patients report 'good' overall experience of general practice

Public satisfaction with GP services remains high, with 82% of patients reporting...

GPs condemn 'deafening silence' from chancellor on COVID support funding

GPs condemn 'deafening silence' from chancellor on COVID support funding

GP leaders have condemned a 'deafening silence' on COVID-19 relief funding for general...

Viewpoint: How has the government handled coronavirus? I feel a rant coming on

Viewpoint: How has the government handled coronavirus? I feel a rant coming on

A national newspaper asked readers how well the government had handled coronavirus....

General Practice Insights: The future of the patient consultation after COVID-19

General Practice Insights: The future of the patient consultation after COVID-19

Welcome to the first of our General Practice Insights reports on key issues for the...

Pandemic could shatter social prescribing as one in three link workers plan to quit

Pandemic could shatter social prescribing as one in three link workers plan to quit

GPs have demanded more resources to support social prescribers after a poll found...

GPs say at least half of patient consultations should be carried out remotely after COVID-19

GPs say at least half of patient consultations should be carried out remotely after COVID-19

A GPonline survey of more than 500 GPs has predicted that over half of patient appointments...